NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521,523 | +0.1% | 5,120 | -0.9% | 0.29% | -1.4% |
| Q2 2023 | $521,200 | +5.7% | 5,165 | -3.6% | 0.29% | -1.7% |
| Q1 2023 | $493,120 | +3.4% | 5,360 | +2.0% | 0.30% | -1.7% |
| Q4 2022 | $476,734 | +21.6% | 5,255 | +1.9% | 0.30% | +19.8% |
| Q3 2022 | $392,000 | -10.1% | 5,155 | -0.1% | 0.25% | -7.7% |
| Q2 2022 | $436,000 | -2.5% | 5,160 | +1.3% | 0.27% | +18.7% |
| Q1 2022 | $447,000 | +5.2% | 5,095 | +4.8% | 0.23% | +8.5% |
| Q4 2021 | $425,000 | +18.7% | 4,860 | +11.2% | 0.21% | +5.0% |
| Q3 2021 | $358,000 | -8.4% | 4,372 | +2.1% | 0.20% | -3.8% |
| Q2 2021 | $391,000 | +23.7% | 4,282 | +15.9% | 0.21% | +14.1% |
| Q1 2021 | $316,000 | -5.1% | 3,693 | +4.7% | 0.18% | -10.7% |
| Q4 2020 | $333,000 | +20.7% | 3,526 | +11.0% | 0.21% | +3.0% |
| Q3 2020 | $276,000 | +10.0% | 3,176 | +10.6% | 0.20% | -1.5% |
| Q2 2020 | $251,000 | +7.7% | 2,871 | +1.8% | 0.20% | -13.6% |
| Q1 2020 | $233,000 | – | 2,821 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |